Device Trial Radar · NCT07538609
The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study
Last checked: Nov 20, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Aug 25, 2026
Primary completion
May 2029
Study completion May 2031
Sponsor
- Lead sponsor
- W.L.Gore & AssociatesNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 20, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a prospective, multicenter, single-arm post-market clinical study to evaluate the GORE® VIABAHN® FORTEGRA Venous Stent in real-world use.
Conditions
- Venous Thromboses
- Venous Disease
- Venous Leg Ulcer
- Venous Stasis
- Venous Ulcer
- Venous Stenosis
- Venous Occlusion
- Vein Thrombosis
Interventions
GORE® VIABAHN® FORTEGRA Venous StentDevice
Treatment with the GORE® VIABAHN® FORTEGRA Venous Stent.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary effectiveness as assessed by primary patencyTime frame: 12 months
- Primary safety as assessed by SAEsTime frame: 30 days
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Vascular Care Connecticut
Darien, Connecticut · Recruiting
Medstar Washington Haspital Center
Washington D.C., District of Columbia · Recruiting
Baylor Research Institute
Dallas, Texas · Recruiting
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.